- Home
- ICU vs MCVT Comparison
ICU vs MCVT Comparison
Compare ICU & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- MCVT
- Stock Information
- Founded
- ICU 2018
- MCVT 2007
- Country
- ICU United States
- MCVT United States
- Employees
- ICU N/A
- MCVT N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- MCVT Finance Companies
- Sector
- ICU Health Care
- MCVT Finance
- Exchange
- ICU Nasdaq
- MCVT Nasdaq
- Market Cap
- ICU 10.4M
- MCVT 9.3M
- IPO Year
- ICU N/A
- MCVT N/A
- Fundamental
- Price
- ICU $0.33
- MCVT $1.90
- Analyst Decision
- ICU
- MCVT
- Analyst Count
- ICU 0
- MCVT 0
- Target Price
- ICU N/A
- MCVT N/A
- AVG Volume (30 Days)
- ICU 1.2M
- MCVT 18.9K
- Earning Date
- ICU 08-12-2025
- MCVT 08-13-2025
- Dividend Yield
- ICU N/A
- MCVT N/A
- EPS Growth
- ICU N/A
- MCVT N/A
- EPS
- ICU N/A
- MCVT 0.19
- Revenue
- ICU $428,000.00
- MCVT $3,246,479.00
- Revenue This Year
- ICU $754.07
- MCVT N/A
- Revenue Next Year
- ICU $100.09
- MCVT N/A
- P/E Ratio
- ICU N/A
- MCVT $10.02
- Revenue Growth
- ICU N/A
- MCVT N/A
- 52 Week Low
- ICU $0.31
- MCVT $1.13
- 52 Week High
- ICU $13.85
- MCVT $3.88
- Technical
- Relative Strength Index (RSI)
- ICU 10.59
- MCVT 58.71
- Support Level
- ICU $0.31
- MCVT $1.81
- Resistance Level
- ICU $1.30
- MCVT $1.93
- Average True Range (ATR)
- ICU 0.10
- MCVT 0.07
- MACD
- ICU -0.09
- MCVT -0.01
- Stochastic Oscillator
- ICU 1.11
- MCVT 72.22
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.